%0 Journal Article %A Palmer, Melissa %A Jennings, Lee %A Silberg, Debra %A Bliss, Caleb %A Martin, Patrick %D 2018 %T Additional file 3: of A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis %U https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_of_A_randomised_double-blind_placebo-controlled_phase_1_study_of_the_safety_tolerability_and_pharmacodynamics_of_volixibat_in_overweight_and_obese_but_otherwise_healthy_adults_implications_for_treatment_of_non-alcoholic_steatohepatitis/5995705 %R 10.6084/m9.figshare.5995705.v1 %2 https://springernature.figshare.com/ndownloader/files/10767754 %K Volixibat %K SHP626 %K LUM002 %K Non-alcoholic steatohepatitis %K Non-alcoholic fatty liver disease %K Apical sodium-dependent bile acid transporter (ASBT) %K Cholesterol %K Obesity %X Figure S1. Frequency of stool hardness during treatment (Bristol Stool Chart scores). (PDF 1081 kb) %I figshare